Skip to main content

Table 3 Characteristics of ALT responders and non-responders before and after glutathione treatment

From: Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study

 

ALT responders (n = 15)

ALT non-responders (n = 14)

Before treatment

After treatment

P-value

Before treatment

After treatment

P-value

Age (year)

50.7 ± 12.1

-

61.7 ± 12.4

-

Male/female (n)

9 (6)

-

5 (9)

-

Dyslipidemia (%)

12 (80.0)

-

12 (85.7)

-

Statin (%)

4 (26.7)

-

8 (57.1)

-

Diabetes (%)

5 (33.3)

-

9 (64.3)

-

BMI (kg/m2)

26.5 ± 4.1

26.5 ± 4.0

0.23

26.6 ± 3.8

26.4 ± 3.9

0.45

FBS (mg/dL)

115.7 ± 37.9

113.0 ± 23.0

0.38

121.4 ± 31.2

128.2 ± 31.4

0.004

IRI (μU/mL)

23.5 ± 22.7

17.9 ± 14.3

0.14

22.6 ± 38.0

30.5 ± 31.4

0.11

HbA1c (%)

5.94 ± 1.03

6.08 ± 1.10

0.017

6.9 ± 1.2

6.89 ± 1.28

0.14

HDL cholesterol (mg/dL)

60.3 ± 18.6

57.4 ± 16.7

0.001

49.7 ± 11.7

52.2 ± 13.8

0.08

LDL cholesterol (mg/dL)

124.5 ± 33.1

117.1 ± 34.8

0.06

102.9 ± 18.6

104.1 ± 14.5

0.41

Triglycerides (mg/dL)

202.4 ± 164.1

178.8 ± 157.6

0.15

187.6 ± 103.3

146.2 ± 62.1

0.003

NEFA (μEq/L)

720.2 ± 285.0

576.0 ± 230.1

0.032

563.3 ± 143.0

473.9 ± 170.7

0.13

AST (IU/L)

46.3 ± 20.2

40.0 ± 20.7

0.11

47.1 ± 14.1

55.8 ± 19.3

0.003

ALT (IU/L)

77.1 ± 38.6

47.9 ± 28.1

<0.0001

60.1 ± 32.2

68.9 ± 36.3

0.005

GGT (IU/L)

81.9 ± 58.0

64.8 ± 48.4

0.07

58.0 ± 26.6

68.5 ± 48.3

0.06

Ferritin (ng/mL)

260.2 ± 164.5

217.7 ± 162.3

0.015

176.6 ± 126.1

169.5 ± 109.9

0.28

Platelet count (×104 /μL)

20.3 ± 4.6

20.2 ± 4.7

0.45

21.3 ± 6.8

21.8 ± 6.0

0.25

Type IV collagen 7 s

4.61 ± 1.13

4.39 ± 1.06

0.10

5.59 ± 2.51

5.42 ± 1.49

0.13

Glutathione in protein fraction (μM)

1.53 ± 0.92

0.88 ± 0.53

0.004

1.27 ± 0.83

1.00 ± 0.77

0.24

Glutathione in deprotenized fraction (μM)

0.017 ± 0.020

0.019 ± 0.029

0.60

0.036 ± 0.057

0.018 ± 0.017

0.19

CAP (db/m)

300.3 ± 41.1

285.1 ± 53.2

0.049

290.4 ± 50.2

285.8 ± 44.9

0.31

LSM (kPa)

8.71 ± 4.63

7.91 ± 4.22

0.19

11.36 ± 5.05

10.9 ± 4.38

0.32

  1. Data are expressed as mean ± standard deviation
  2. Abbreviations: BMI body mass index, FBS fasting blood sugar, IRI immunoreactive insulin, HBA1c hemoglobin A1c, HDL cholesterol high density lipoprotein cholesterol, LDL cholesterol low density lipoprotein cholesterol, NEFA non-esterified fatty acid, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT γ-glutamyl transpeptidase, CAP controlled attenuation parameter, LSM liver stiffness measurement